📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A product of independent beta probabilities dose escalation design for dual-agent phase I trials. (2015)

First Author: Mander AP

Attributed to: Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.6434

PubMed Identifier: 25630638

Publication URI: http://europepmc.org/abstract/MED/25630638

Type: Journal Article/Review

Volume: 34

Parent Publication: Statistics in medicine

Issue: 8

ISSN: 0277-6715